Prognostic value of of F18-FDG PET/CT and/or Planar Bone Scintigraphy (BS) in Patients with Breast Cancer and Suspected Bone Metastases

被引：0
|
作者：
Gajwani, Prateek [1 ]
Crandall, John [1 ]
Wahl, Richard [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1321
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparison of the diagnostic value of F-18 FDG PET(-CT) and bone scintigraphy in lung cancer patients with bone metastases
    Rendl, G.
    Stark, H.
    Rettenbacher, L.
    Studnicka, M.
    Pirich, C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S424 - S424
  • [2] Comparison of 18F FDG-PET/CT with Bone Scintigraphy for the Detection of Bone Metastases in Patients with Breast Cancer
    Sanchez Sanchez, R.
    Rebollo Aguirre, A.
    Trivino Ibanez, E.
    Guzman Caro, G.
    Aroui Luquin, T.
    Testart Dardel, N.
    Rodriguez Fernandez, A.
    Gomez Rio, M.
    Llamas Elvira, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S470 - S471
  • [3] Evaluation of bone scintigraphy and 18F-FDG PET/CT in bone metastases of lung cancer patients
    Portilla-Quattrociocchi, H.
    Banzo, I.
    Martinez-Rodriguez, I.
    Quirce, R.
    Jimenez-Bonilla, J.
    de Arcocha Torres, M.
    Medina-Quiroz, P.
    del Castillo, R.
    Rubio-Vassallo, A.
    Carril, J. M.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2011, 30 (01): : 2 - 7
  • [4] Bone metastases detection in breast cancer: F18-FDGpositron emission tomography (FDG-PET) or bone scintigraphy (BS)?
    Matteucci, F.
    Galassi, R.
    Moretti, A.
    Lombini, F.
    Bedei, C.
    Pennacchia, B.
    Fiorentini, G.
    Bertocco, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S247 - S247
  • [5] Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT
    Stefan Krüger
    Andreas K. Buck
    Felix M. Mottaghy
    Ellen Hasenkamp
    Sandra Pauls
    Christian Schumann
    Thomas Wibmer
    Tobias Merk
    Vinzenz Hombach
    Sven N. Reske
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1807 - 1812
  • [6] Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT
    Krueger, Stefan
    Buck, Andreas K.
    Mottaghy, Felix M.
    Hasenkamp, Ellen
    Pauls, Sandra
    Schumann, Christian
    Wibmer, Thomas
    Merk, Tobias
    Hombach, Vinzenz
    Reske, Sven N.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (11) : 1807 - 1812
  • [7] Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer
    Al-Muqbel, Kusai M.
    Yaghan, Rami J.
    [J]. MEDICINE, 2016, 95 (21)
  • [8] Prognostic value of F18-FDG PET/CT and autoimmune antibody panels in patients with suspected paraneoplastic syndromes
    Crandall, John
    Joshi, Keya
    Wahl, Richard
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [9] Diagnostic performance of 18F-fluorodeoxyglucose PET/CT and bone scintigraphy in breast cancer patients with suspected bone metastasis
    Naoki Niikura
    Jun Hashimoto
    Toshiki Kazama
    Jun Koizumi
    Rin Ogiya
    Mayako Terao
    Risa Oshitanai
    Toru Morioka
    Banri Tsuda
    Takuho Okamura
    Yuki Saito
    Keiko Iwaisako
    Takayuki Iwamoto
    Naoki Hayashi
    Yutaka Imai
    Yutaka Tokuda
    [J]. Breast Cancer, 2016, 23 : 662 - 667
  • [10] Diagnostic performance of 18F-fluorodeoxyglucose PET/CT and bone scintigraphy in breast cancer patients with suspected bone metastasis
    Niikura, Naoki
    Hashimoto, Jun
    Kazama, Toshiki
    Koizumi, Jun
    Ogiya, Rin
    Terao, Mayako
    Oshitanai, Risa
    Morioka, Toru
    Tsuda, Banri
    Okamura, Takuho
    Saito, Yuki
    Iwaisako, Keiko
    Iwamoto, Takayuki
    Hayashi, Naoki
    Imai, Yutaka
    Tokuda, Yutaka
    [J]. BREAST CANCER, 2016, 23 (04) : 662 - 667
12345